This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™

Sponsored by Baylor Research Institute

About this trial

Last updated 4 years ago

Study ID

020-291

Status

Recruiting

Type

Interventional

Phase

Phase 4

Placebo

Yes

Accepting

18-75 Years
14 to 48 Years
Female
Female

Trial Timing

Ended 8 months ago

What is this trial about?

Effects of norethindrone acetate (NTA) in patients with Nexplanon.

What are the participation requirements?

Yes

Inclusion Criteria

- Between the ages of 18-48

- Between ages of 14-17 with parental/guardian permission

- Women desiring placement of Nexplanon™

- Willing to keep a daily symptom calendar

- Keep appointments

- Women not desiring to become pregnant in the next 2 years

No

Exclusion Criteria

- Known or suspected Pregnancy

- Less than 8weeks postpartum

- Menarche less than two years ago

- Current or past history of thrombosis or thromboembolic disorders

- Hepatic tumors (benign or malignant)

- Active liver disease

- Undiagnosed abnormal genital bleeding

- Undiagnosed headaches

- Known or suspected carcinoma of the breast or personal history of breast cancer

- Hypersensitivity to any of the components in Nexplanon™

- BMI greater than 40

- Depomedroxyprogesterone acetate injection in the previous 12 weeks

Locations

Location

Status

Recruiting